foto micro

Heads

  • Ignacio Gadea Gironés (Associate Professor, UAM)
  • Jaime Esteban Moreno (Associate Professor, UAM)
  • Ricardo Fernández roblas (Associate Professor, UAM)

Research staff

  • Tomás Javier Zapardiel Ferrero
  • Concepción Pérez-Jorge Peremarch

Trainee staff

  • María García Pedrazuela
  • Iris González Pallarés
  • Marta Martínez Pérez
  • Mª Carmen Muñoz Egea
  • Laura Prieto Borja
  • Graciela Rodríguez Sevilla

Main lines of research

Development of new vaccines against herpes simplex virus

Development of new vaccines against herpes simplex virus using pseudorabies virus as a vehicle and evaluation of candidate vaccines using an experimental mouse model. In collaboration with the Department of Microbiology at the UAM.

* Principal Investigator: Ignacio Gadea Gironés


Diagnosis, pathogenesis and treatment of biofilm-associated infections

Evaluation of new technologies for the diagnosis of infections associated with implants, including the evaluation of molecular techniques; sonication of catheters, prostheses and other devices; characterization of the clonality of isolates of prosthetic infection; and study of the antimicrobial susceptibility of biofilms. In collaboration with various national and international centers.

Pathogenesis and treatment of infections caused by rapidly growing mycobacteria

Characterization of biofilms formed by rapidly growing mycobacteria, including evaluation of new treatments, ultrastructural studies, characterization of polyclonality isolates, and clinical studies. In collaboration with national hospitals within the mycobacteria study group of the SEIMC.

Development of new biomaterials of biomedical interest

Development of new intelligent biomaterials of biomedical interest for use in orthopedic pathologies and evaluation of the anti-bacterial adhesion ability thereof; biofilm formation; cell competition studies; antimicrobial loading; functionalization of materials. In collaboration with various national and international consortia.

* Principal Investigator: Jaime Esteban Moreno


Proanthocyanidins and their effects in urinary tract infection

Evaluation of various proanthocyanidin molecules for the prevention of urinary tract infection in in vitro studies in cells and bacteria and in experimental animal studies. In collaboration with the CSIC.

* Principal Investigator: Ricardo Fernández Roblas


Publications (2014)

Total number of Publications

Nº of Publications with IF

Accumulated IF

Average

IF

Nº of Publications (Q1)

(%) Q1

12

10

41,00

4,10

6

60,00%


1. Puig-Asensio M, Padilla B, Garnacho-Montero J, Zaragoza O, Aguado JM, Zaragoza R, Montejo M, Muñoz P, Ruiz-Camps I, Cuenca-Estrella M, Almirante B; CANDIPOP Project (incluye I Gadea); GEIH-GEMICOMED (SEIMC); REIPI..Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.Clin Microbiol Infect. 2014 Apr;20(4):O245-54. doi: 10.1111/1469-0691.12380. Epub 2013 Oct 11..PudMed PMID:24125548


2. Ripoll A, Galán JC, Rodríguez C, Tormo N, Gimeno C, Baquero F, Martínez-Martínez L, Cantón R; SEIMC Quality Control Study Group(incluye R. Fernandez Roblas)..Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains.J Clin Microbiol. 2014 Jan;52(1):122-9. doi: 10.1128/JCM.02340-13. Epub 2013 Oct 23..PudMed PMID:24153133


3. Guinea J, Zaragoza Ó, Escribano P, Martín-Mazuelos E, Pemán J, Sánchez-Reus F, Cuenca-Estrella M; CANDIPOP Project (incluye I Gadea), GEIH-GEMICOMED (SEIMC), and REIPI..Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.Antimicrob Agents Chemother. 2014;58(3):1529-37. doi: 10.1128/AAC.02155-13. Epub 2013 Dec 23..PudMed PMID:24366741


4. Pérez-Jorge C, Valdazo-Rojo M, Blanco-García A, Esteban-Moreno J.Mycobacterium tuberculosis as cause of therapeutic failure in prosthetic joint infections.Enferm Infecc Microbiol Clin. 2014 Mar;32(3):204-5. doi: 10.1016/j.eimc.2013.04.022. Epub 2014 Feb 5. .PudMed PMID:24508372


5. Puig-Asensio M, Pemán J, Zaragoza R, Garnacho-Montero J, Martín-Mazuelos E, Cuenca-Estrella M, Almirante B;Prospective Population Study on Candidemia in Spain (CANDIPOP)(incluye I Gadea) Project; Hospital Infection Study Group (GEIH);Medical Mycology Study Group (GEMICOMED) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC); Spanish Network for Research in Infectious Diseases..Impact of therapeutic strategies on the prognosis of candidemia in the ICU.Crit Care Med. 2014 Jun;42(6):1423-32. doi: 10.1097/CCM.0000000000000221..PudMed PMID:24557426


6. Prieto-Pérez L, Pérez-Tanoira R, Petkova-Saiz E, Pérez-Jorge C, Lopez-Rodriguez C, Alvarez-Alvarez B, Polo-Sabau J, Esteban J..Osteomyelitis: a descriptive study.Clin Orthop Surg. 2014 Mar;6(1):20-5. doi: 10.4055/cios.2014.6.1.20. Epub 2014 Feb 14..PudMed PMID:24605185


7. Fernández-Ruiz M, Aguado JM, Almirante B, Lora-Pablos D, Padilla B, Puig-Asensio M, Montejo M, García-Rodríguez J, Pemán J, Ruiz Pérez de Pipaón M, Cuenca-Estrella M; CANDIPOP Project (Incluye I Gadea); GEIH-GEMICOMED (SEIMC); REIPI..Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.Clin Infect Dis. 2014 May;58(10):1413-21. doi: 10.1093/cid/ciu158. Epub 2014 Mar 18..PudMed PMID:24642553


8. Muñoz-Egea MC, García-Pedrazuela M, Esteban J.[In vitro susceptibility of rapidly growing mycobacteria biofilms against different antimicrobials].Enferm Infecc Microbiol Clin. 2015 Feb;33(2):136-7. doi: 10.1016/j.eimc.2014.04.010. Epub 2014 Jul 11. Spanish. .PudMed PMID:25027696


9. Muñoz-Egea MC, Blanco A, Fernández-Roblas R, Gadea I, García-Cañete J, Sandoval E, Valdazo M, Esteban J.Clinical and microbiological characteristics of patients with septic arthritis: A hospital-based study.J Orthop. 2014 Jun;11(2):87-90. doi: 10.1016/j.jor.2014.04.002..PudMed PMID:25104892


10. Muñoz-Egea MC, Cabello-Úbeda A, Fernández-Roblas R, Gadea I.[Decreased level of consciousness, fever, and dyspnea in an HIV-infected patient].Rev Argent Microbiol. 2014 Jul-Sep;46(3):271-2. doi: 10.1016/S0325-7541(14)70082-3. Epub 2014 Oct 15. Spanish. .PudMed PMID:25444137


11. Perez-Tanoira R, Sanchez-Patan F, Jimenez-Girón A, Fernandez-Roblas R, Esteban J, Fernandez-Guerrero ML.Tolerance and safety of intravenous streptomycin therapy in patients with tuberculosis.Infection. 2014 Jun;42(3):597-8. doi: 10.1007/s15010-014-0621-5. Epub 2014 Apr 19. No abstract available. .PudMed PMID:24748409


12. Esteban J, Sorli L, Alentorn-Geli E, Puig L, Horcajada JP.Conventional and molecular diagnostic strategies for prosthetic joint infections.Expert Rev Mol Diagn. 2014 Jan;14(1):83-96. doi: 10.1586/14737159.2014.861327. Epub 2013 Dec 6. Review..PudMed PMID:24308408


Projects (2013)

1. "Biocerámicas para ingeniería tisular – FUNDAMICRO" Investigador Principal Dr. J. Esteban Moreno

Proyecto Público Competitivo S2009/MAT-1472-1 BITI.

2. "Funcionalización superficial de materiales para aplicaciones de alto valor añadido (FUNCOAT)". Investigador Principal Dr. J. Esteban Moreno. Proyecto Público Competitivo CSD 2008-0023 FUNCOAT.

3. "Proantocianidinas de tipo A: estudio de su metabolismo por la microbiota intestinal y acción protectora frente a infecciones del tracto urinario". Investigador Principal Dr. R. Fernández Roblas. Proyecto Público Competitivo AGL2010-17499.


Patents

P 201030720, PCT/ES2011/070342 "Materiales de titanio anodizados con flúor".

P 201100655 (4) PCT/ES2012/000160 EP12797636.3 "Materiales biocerámicos para el tratamiento de la osteomielitis"